Clinical Trial Update: Serial Infusions of Allogeneic Mesenchymal Stem Cells in Cardiomyopathy Patients With Left Ventricular Assist Device [Phase 2]

View source ↗

Summary

Phase 2 trial investigating serial infusions of allogeneic mesenchymal stem cells in cardiomyopathy patients with left ventricular assist devices; study TERMINA…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ischemic Heart Disease
• Non-ischemic Cardiomyopathy

Drugs mentioned

• Mesenchymal stem cells (mesenchymal stem cells)

Snippet

Sponsor: Medstar Health Research Institute | Conditions: Ischemic Heart Disease, Non-ischemic Cardiomyopathy | Phase 2 | Status: TERMINATED | Results posted: 2022-02-02